Sancuso Patch
Product Images NDC 66220-637

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sancuso (NDC 66220-637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cumberland Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (San0f 0000 01)

Chemical structure diagram of granisetron, the active ingredient in SANCUSO. The image shows the molecular arrangement and bonding within the granisetron compound.*

FDA Label Image

Figure (San0f 0000 02)

A line graph showing plasma concentration of granisetron (ng/mL) over time (hours) in all subjects (n=24). Concentration peaks around 48 to 72 hours then gradually declines through 168 hours.*

FDA Label Image

Figure (San0f 0000 03)

An illustration showing the application of a SANCUSO patch (granisetron 3.1 mg/24h) on the upper arm of a person. The image depicts a rectangular transdermal patch positioned on the upper arm area, demonstrating the recommended placement site for the medication.*

FDA Label Image

Figure (San0f 0000 04)

An instructional illustration showing two hands pulling the protective liner off a SANCUSO 3.1 mg/24h granisetron transdermal patch carton. This image demonstrates how to remove the protective cover from the patch packaging before application.*

FDA Label Image

Figure (San0f 0000 05)

An instructional illustration showing hands removing a SANCUSO transdermal granisetron patch from packaging. The sequence depicts peeling back a layer of the outer packaging to expose the patch inside, illustrating the correct method to access the patch for application.*

FDA Label Image

Figure (San0f 0000 06)

Illustration showing the application of a SANCUSO 3.1 mg/24h granisetron transdermal patch. The diagram depicts hands peeling away the protective backing from the adhesive side of the patch prior to application on the skin.*

FDA Label Image

Figure (San0f 0000 07)

An instructional illustration showing how to apply the SANCUSO transdermal patch. The first image depicts a person holding the patch near the upper arm with the protective liners partially removed. The second image shows the patch being pressed onto the upper arm, demonstrating proper placement and adhesion technique.*

FDA Label Image

Principal Display Panel – 168 H Pouch Label (San0f 0000 08)

Sancuso granisetron transdermal system patch delivering 3.1 mg/24 hours is shown. The label indicates it is a 7-day transdermal system containing 34.3 mg of granisetron in each 52 cm² patch. Packaged for Cumberland Pharmaceuticals Inc., the label includes usage and storage instructions, and the product's NDC barcode is visible along with the company logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.